Kymera Therapeutics 주식 가격. KYMR - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

36.375

매수가

36.27

매도가

36.38

거래량

96,327

36.02 일간 변동폭 38.36

29.33 52주 범위 53.27

market_cap

2.356B

전일 종가

37.32

개장가

37.56

최근 거래 시간

36.3398

마지막 거래 시간

02:12:15

재정 규모

US$ 3,544,663

VWAP

36.7982

평균 볼륨(3m)

484,946

발행 주식

64,765,274

배당수익률

주가수익률

-16.17

주당순이익(EPS)

-2.27

매출

78.59M

순이익

-146.96M

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causin... Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.kymeratx.com

본부

Wilmington, Delaware, USA

설립됨

Kymera Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker KYMR. The last closing price for Kymera Therapeutics was US$37.32. Over the last year, Kymera Therapeutics shares have traded in a share price range of US$ 29.33 to US$ 53.27.

Kymera Therapeutics currently has 64,765,274 shares in issue. The market capitalisation of Kymera Therapeutics is US$2.42 billion. Kymera Therapeutics has a price to earnings ratio (PE ratio) of -16.17.

Kymera Therapeutics to Participate in Upcoming February Investor Conferences

WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...

Form 8-K - Current report

Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

KT-621 (STAT6) Phase 1 healthy volunteer trial ongoing, with data expected in 2Q25 Kymera plans to initiate a KT-621 Phase 1b trial in atopic dermatitis (AD) patients in 2Q25 with data in 4Q25...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-1.935	-5.05090054816	38.31	39.88	36.02	399417	38.50265967	CS
4	-1.235	-3.28370114331	37.61	45.31	35.57	501137	40.69591841	CS
12	-5.655	-13.454675232	42.03	49.3527	35.57	484946	42.0958679	CS
26	-4.665	-11.3669590643	41.04	53.27	35.57	445212	44.71934396	CS
52	-0.635	-1.71575249932	37.01	53.27	29.33	524676	40.9172564	CS
156	-5.715	-13.5780470421	42.09	53.27	9.6	604852	29.9251648	CS
260	3.455	10.4951397327	32.92	91.92	9.6	512500	34.35613388	CS

KYMR - Frequently Asked Questions (FAQ)

What is the current Kymera Therapeutics share price?

The current share price of Kymera Therapeutics is US$ 36.375

How many Kymera Therapeutics shares are in issue?

Kymera Therapeutics has 64,765,274 shares in issue

What is the market cap of Kymera Therapeutics?

The market capitalisation of Kymera Therapeutics is USD 2.42B

What is the 1 year trading range for Kymera Therapeutics share price?

Kymera Therapeutics has traded in the range of US$ 29.33 to US$ 53.27 during the past year

What is the PE ratio of Kymera Therapeutics?

The price to earnings ratio of Kymera Therapeutics is -16.17

What is the cash to sales ratio of Kymera Therapeutics?

The cash to sales ratio of Kymera Therapeutics is 30.23

What is the reporting currency for Kymera Therapeutics?

Kymera Therapeutics reports financial results in USD

What is the latest annual turnover for Kymera Therapeutics?

The latest annual turnover of Kymera Therapeutics is USD 78.59M

What is the latest annual profit for Kymera Therapeutics?

The latest annual profit of Kymera Therapeutics is USD -146.96M

What is the registered address of Kymera Therapeutics?

The registered address for Kymera Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Kymera Therapeutics website address?

The website address for Kymera Therapeutics is www.kymeratx.com

Which industry sector does Kymera Therapeutics operate in?

Kymera Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
CYNCYNGN Inc	US$ 0.1314 (118.27%)	985.5M
MGOLMGO Global Inc	US$ 0.7544 (81.78%)	428.15M
BNAIBrand Engagement Network Inc	US$ 0.7205 (75.73%)	197.33M
BDRXBiodexa Pharmaceuticals PLC	US$ 6.47 (58.97%)	19.55M
PNBKPatriot National Bancorp Inc	US$ 2.1394 (47.54%)	50.98M
PLRXPliant Therapeutics Inc	US$ 3.20 (-58.92%)	11.8M
SMTCSemtech Corp	US$ 37.61 (-31.00%)	11.09M
LTRYLottery com Inc	US$ 1.1264 (-29.60%)	5.46M
GSIWGarden Stage Ltd	US$ 0.5712 (-27.52%)	3.31M
ATPCAgape ATP Corporation	US$ 0.951 (-25.12%)	309.2k
CYNCYNGN Inc	US$ 0.1314 (118.27%)	985.52M
MGOLMGO Global Inc	US$ 0.7545 (81.81%)	428.17M
OCEAOcean Biomedical Inc	US$ 0.134 (0.83%)	400.15M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0677 (25.37%)	197.72M
BNAIBrand Engagement Network Inc	US$ 0.7204 (75.71%)	197.34M